A better approach, the group explained, would be to look for MGUS in conjunction with autoimmune disease in the general population. Exactly that type of data was available from a trial conducted ...

USA: A recent study published in JAMA Network Open has found that the use of glucagon-like peptide-1 (GLP-1) receptor ...

GLP-1RAs were associated with lower risk for major adverse cardiovascular and cerebrovascular events in MGUS with type 2 diabetes.

Monoclonal gammopathy of undetermined significance (MGUS) and smoldering myeloma are both precursor conditions that can turn into multiple myeloma, a type of cancer that affects plasma cell production ...

Background: Monoclonal Gammopathy of Undetermined Significance (MGUS) and Multiple Myeloma (MM) are hematologic conditions characterized by demographic and clinical feature variations. Examining the ...

The three types of plasma cell neoplasms include monoclonal gammopathy of undetermined significance (MGUS), plasmacytoma, and multiple myeloma.

Glucagon-like peptide-1 (GLP-1) agonists, widely used for glycemic control and weight loss in type 2 diabetes mellitus (T2DM), have demonstrated cardiovascular, renal, and anti-cancer benefits, ...